Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity
Abstract Background The failure of novel therapies effective in preclinical animal models largely reflects the fact that current models do not really mimic the pathological/therapeutic features of glioblastoma (GBM), in which the most effective temozolomide chemoradiotherapy (RT/TMZ) regimen can onl...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2023-05-01
|
| Serier: | Journal of Experimental & Clinical Cancer Research |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s13046-023-02686-1 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
